The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort

Uslu, SGulle, SCan, GSenel, SCapar, SDalkilic, HEAkar, SKoca, SSTufan, AYazici, AYilmaz, SInanc, NBirlik, MSolmaz, DCefle, AGoker, BYolbas, SKrough, NSYilmaz, NErten, SBes, CSoysal, OOzturk, MAHaznedaroglu, SYavuz, SDireskeneli, HOnen, FSari, I2025-04-102025-04-102326-5191http://hdl.handle.net/20.500.14701/43023EnglishThe Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO CohortMeeting Abstract2326-5205